Biologics in juvenile idiopathic arthritis: a narrative review
- European Journal of Pediatrics
Authors: Federica Vanoni, Francesca Minoia, Clara Malattia
Publisher: Springer Berlin Heidelberg
What is Known:
• NSAID, intra-articular injection of corticoids, and methotrexate are the mainstay in treatment of JIA.
• In aggressive JIA, these treatments may be not sufficient to reach disease remission and to prevent long term disability.
What is New:
• In recent years, management of JIA has significantly improved with the development of biologic therapies that allowed children with arthritis to reach a normal growth and to achieve a good long-term functional outcome.